15 studies consisting of 3,290 samples of Bladder cancer, Endometrial cancer, Melanoma and Non-small cell lung cancer were run in OncoPrint to find Alteration frequency of EGFR, HRAS and MAPK3 (Fig. 5). Here, MAPK3 is linked to melanoma.